TACkling Cancer by Targeting Selective Protein Degradation

TACkling Cancer by Targeting Selective Protein Degradation

Targeted protein degradation has emerged as an alternative therapy against cancer, offering several advantages over traditional inhibitors. The new degrader drugs provide different therapeutic strategies: they could cross the phospholipid bilayer membrane by the addition of specific moieties to extr...

Full description

Bibliographic Details
Main Authors: María del Mar Noblejas-López, David Tébar-García, Raquel López-Rosa, Ana Alcaraz-Sanabria, Pablo Cristóbal-Cueto, Alejandro Pinedo-Serrano, Lorenzo Rivas-García, Eva M. Galán-Moya
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Pharmaceutics
Subjects:
protein degrader
PROTAC
PHOTAC
CLIPTAC
AUTAC
ATTEC
Online Access:https://www.mdpi.com/1999-4923/15/10/2442

Internet

https://www.mdpi.com/1999-4923/15/10/2442

Similar Items